K. Monsieurs

Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.

C. van Broeckhoven, V. Procaccio, R. Ellis, 1995, American journal of human genetics.

Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

G. Comi, M. Lehane, A. Urwyler, 1998, American journal of human genetics.

Slower recovery of muscle phosphocreatine in malignant hyperthermia-susceptible individuals assessed by 31P-MR spectroscopy

L. Bossaert, F. Wuyts, Jean-Jacques Martin, 1997, Journal of Neurology.

Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.

M. Lehane, K. Keating, T. McCarthy, 1994, Human molecular genetics.

A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees.

C. van Broeckhoven, A. Reis, T. Deufel, 1997, Human molecular genetics.

Gly341Arg mutation indicating malignant hyperthermia susceptibility: specific cause of chronically elevated serum creatine kinase activity

C. Broeckhoven, Jean-Jacques Martin, L. Heytens, 1998, Journal of the Neurological Sciences.

Malignant hyperthermia susceptibility in a patient with concomitant motor neuron disease

C. Broeckhoven, Jean-Jacques Martin, I. Dehaene, 1996, Journal of the Neurological Sciences.

Genetic mapping of the β1- and γ-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility

A. Stewart, P. Hopkins, R. Sengers, 1993 .